Home › Linfoma follicolare › Washington › Seattle
Studi clinici su Linfoma follicolare a Seattle, WA
15 studi su Linfoma follicolare cercano partecipanti presso sedi a Seattle e dintorni (entro circa 30 miglia). Apri uno studio per vedere chi può partecipare e come contattare il team.
Testo ufficiale dello studio (inglese)
Stai reclutando per uno studio? Mettilo in evidenza in cima alla pagina — $99 per 30 giorni →
A Study to Evaluate Safety, PK, PD and Efficacy of AZD5492, a T Cell-engaging Antibody Targeting CD20 in Subjects With R/R B-Cell Malignancies.
In reclutamentoFase 1/2
- Research Site, Seattle
A Dose-Escalation and Expansion Study of Tacabrutideg (BGB-16673) in Participants With B-Cell Malignancies
In reclutamentoFase 1/2
- Fred Hutchinson Cancer Research Center, Seattle
A Study of LY4584180 in Adult Participants With Previously Treated Blood Cancers
In reclutamentoFase 1
- University of Washington - Fred Hutchinson Cancer Center (Seattle Cancer Care Alliance), Seattle
A Study of LY4152199 in Participants With Previously Treated B-cell Malignancies (BAF_FRontier-1 )
In reclutamentoFase 1
- Swedish Cancer Institute (SCI), Seattle
A Study of Debio 0123 in Combination With Temozolomide in Adult Participants With Recurrent or Progressive Glioblastoma and of Debio 0123 in Combination With Temozolomide and Radiotherapy in Adult Participants With Newly Diagnosed Glioblastoma
In reclutamentoFase 1/2
- Fred Hutchinson Cancer Research Center, Seattle
SIGMA (Safusidenib in IDH1 Mutant Glioma Maintenance)
In reclutamentoFase 3
- Fred Hutch Cancer Center, Seattle
Low Dose Mosunetuzumab for the Treatment of Patients With Indolent B-Cell Lymphoma
In reclutamentoFase 2
- Fred Hutch/University of Washington Cancer Consortium, Seattle
This is a Phase 1 Study to Evaluate the Safety of LTZ-301 in Patients With Non-Hodgkin Lymphoma
In reclutamentoFase 1
- Fred Hutchinson Cancer Center, Seattle
Pirtobrutinib and Mosunetuzumab for the Treatment of Relapsed/Refractory Grades 1-3A Follicular Lymphoma, PROMOTE-FL Trial
In reclutamentoFase 2
- Fred Hutch/University of Washington Cancer Consortium, Seattle
Donor Stem Cell Transplant With Treosulfan, Fludarabine, and Total-Body Irradiation for the Treatment of Hematological Malignancies
In reclutamentoFase 2Volontari sani benvenuti
- Fred Hutch/University of Washington Cancer Consortium, Seattle
Study of SGR-1505 in Mature B-Cell Neoplasms
In reclutamentoFase 1
- Fred Hutchinson Cancer Center, Seattle
A Novel Vaccine (EO2463) as Monotherapy and in Combination, for Treatment of Patients With Indolent Non-Hodgkin Lymphoma
In reclutamentoFase 1/2
- University of Washington-Seattle Cancer Care Alliance, Seattle
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
In reclutamentoStudio osservazionale
- Massive Bio SYNERGY-AI site, Seattle
A Study of AC676 for the Treatment of Relapsed/Refractory B-Cell Malignancies
In reclutamentoFase 1
- Swedish Cancer Institute, Seattle
Study of the Clinical Impact of Surgical Correction of Tricuspid Insufficiency in Implantable LVAD Patients
In reclutamento
- University of Washington Medical Center, Seattle
Studi su Linfoma follicolare in altre città
- New York City, NY24 studi
- Milwaukee, WI19 studi
- Nashville, TN18 studi
- Houston, TX18 studi
- Boston, MA17 studi
- Baldwin Park, CA16 studi
- Durham, NC15 studi
- Columbus, OH13 studi
- Salt Lake City, UT13 studi
- San Antonio, TX12 studi
- Chicago, IL12 studi
- Philadelphia, PA12 studi
Altri studi a Seattle
- Cancro del polmone non a piccole cellule53 studi
- Cancro (tutti i tipi)49 studi
- Cancro alla prostata42 studi
- Leucemia mieloide acuta40 studi
- Cancro al seno39 studi
- Cancro metastatico39 studi
- Cancro colorettale34 studi
- Cancro ai polmoni33 studi
- Cancro ovarico30 studi
- Mieloma multiplo22 studi
- Sindromi mielodisplastiche21 studi
- Leucemia linfoblastica acuta21 studi
Fonte: ClinicalTrials.gov, dati recuperati il 5 ott 2026. Ogni studio stabilisce i propri criteri di idoneità; è il team di ricerca a decidere chi può partecipare.